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462 Evaluation of CF database in Republic of Macedonia
T. Jakovska-Maretti1, S. Fustik1, L. Spirevska1. 1CF center, University Pediatric
Clinic, Skopje, Macedonia
The ﬁrst specialized CF centre in R.Macedonia was established in 1996/97 year.
The aims of the study were to determine the incidence of CF (no previous data
available), to follow the evaluation of the disease and further complications.
Methods: Using CF database for demographic, genetic and typical clinical symp-
toms are described.
Results: Totally 100 CF patients (both children and adults) were identiﬁed in
databases with mean age 10.9±12.4 years. The oldest CF patient is 26 years
old.13% of the patients is older than 18year. 80% of the patients were diagnosed
before the age of 1 year. 85% carry the DF508 mutation (65% are homozygote).
42% of them are colonized with Pseudomonas aeruginosa (20% have chronic PA
infection). 90% have exocrine pancreatic insufﬁciency and 29% are malnourished
(BMI< 18.5 kg/m2). 8% of the patients have liver disease, meconium ileus had 5%,
4% have diabetes mellitus and 10% have CF bone disease (3% with osteoporosis).
Mean lung function FEV1 in group of 6−18 years was 89.18±22.5 compared
to FEV1 in patients >18 y (67.7±31.7). We don’t have any patient with lung
transplantation.
Conclusion: Advances in management based on European standards are given in
specialized CF center, and have increased survival in CF in R.Macedonia.
463 The development of cystic ﬁbrosis care in the South West,
including the development and impact of the South and West
Cystic Fibrosis Database: a retrospective review
J. Tyrrell1, S.J. Gooch1, K. Giles1. 1Children’s Centre, Royal United Hospital
Bath, Bath, United Kingdom
Cystic ﬁbrosis, as a relatively rare disease with a distributed and small popula-
tion in the UK, has undergone signiﬁcant transformations in care provision and
commissioning over the past 30 years.
The paper aims to track these transformations with reference to the following:
changes in care provision and the implications of these changes, the challenging
geography of the South West and how shared care arrangements have developed to
overcome this, and the changes in NHS structure and the resulting impact on how
CF care is commissioned.
Patient registries are an essential tool in understanding disease progression. The
South and West CF database was developed in 1995 from a need by local clinicians
to understand their CF population. It now has 12 years of data that clearly show
the changes in CF care presented above, as well as changes in clinical outcomes.
In 1995 there were 62 consultants with an average of 10 patients per consultant
in the South West. 48% (30) consultants had less than 5 patients on their list. In
2006 there were 36 consultants with an average of 23 patients each and only 6%
(2) consultants had less than 5 patients. For patients not receiving care at specialist
centres, 35% of adults and 53% of paediatrics had shared care in 1995; this has
risen to 54% and 66% respectively in 2006.
In addition to providing high quality patient, population and clinical data, the
presence of the database has had a positive impact on working practices in the
region.
464 The UK CF Registry – a successful transition to a web-based
system
E. Gunn1, M. Baker1, A. Larsen1. 1CF Registry, Cystic Fibrosis Trust, London,
United Kingdom
Over the past decade the UKCF Database was established by a multidisciplinary
team using a generic approach to monitor clinical outcomes of patients with CF
in the UK. Software obsolescence and the need for greater sophistication led to
a search for a new patient registry application. The web-based Port CF software
developed by the CFF in the USA was identiﬁed as being appropriate. CFF were
keen to collaborate in order to enhance international comparisons. A licence was
agreed and the software was “anglicised” with the help of appropriate clinical
expertise. The project received national ethical approval. After rigorous testing an
implementation programme was initiated and the registry “rolled-out” to specialist
CF centres. Online helpdesk facilities are available to assist local administrators.
Centres add data direct to the registry in the form of clinical encounters. The
minimum data requirement is demographic and clinical data from an annual review
for each patient. For regional centres sharing care with smaller clinics, data can be
entered at both sites thereby enabling the regional centre to maintain and monitor
overall clinical care. By December 2007, 94 centres and clinics (58/36) have been
implemented. Data collected by the former database has been mapped into the new
CF Registry giving centres access to data from 1999 to date. Data are available
for >6500 patients. Sophisticated analysis is available to each centre using simple
reporting tools. This user friendliness and the ability of each centre to analyse their
own data simply and efﬁciently has been key to the acceptability and take up of
Port CF. The CF Registry will be used to monitor and improve quality of care in
the UK. The Registry Steering Committee will produce an annual report of clinical
outcomes for the prior year to be available in the autumn.
